Understanding Neurotrophic Keratitis: Orientation & Overview
At a Glance
Neurotrophic keratitis damages the corneal nerves that signal pain and support healing, so serious surface injury can develop with little or no discomfort. Early assessment, stage-based treatment, and regular cornea specialist monitoring help protect vision.
If you have been diagnosed with neurotrophic keratitis (NK), you are dealing with a rare and paradoxical condition. While most eye problems cause immediate, sharp pain that forces you to seek help, NK does the opposite: it impairs the eye’s alarm system [1]. This “silence” is why the disease can be so dangerous.
What is Neurotrophic Keratitis?
Neurotrophic keratitis is a degenerative disease of the cornea—the clear, dome-shaped window at the front of your eye [1]. It is caused by damage to the trigeminal nerve, which is responsible for providing sensation to your eye [2].
In a healthy eye, these nerves do more than just feel pain; they act as a support system. They tell your brain when to blink and when to produce tears, and they release “trophic factors”—special proteins that act like fertilizer to keep the corneal surface healthy and help it heal from minor scratches [3][4]. When these nerves are damaged, the eye’s ability to maintain itself is compromised, leading to a breakdown of the corneal surface [3].
A Rare and “Silent” Condition
NK is uncommon. While rates vary, research in specialized French eye clinics found that it affected about 11 out of every 10,000 screened patients (0.11%) [5]. Because it is rare, many general eye doctors may not see it frequently, which is why finding a cornea specialist—an ophthalmologist with advanced training in corneal diseases—is essential for your care [6].
The “core paradox” of NK is that the worse the disease gets, the less you may feel it. Because the sensory nerves are damaged, your eye cannot reliably send pain signals to your brain [1]. You might have a significant injury or ulcer on your eye and feel absolutely nothing [7]. This is why NK is often called a “silent” disease: the absence of pain does not mean the eye is healthy [1].
Common Misunderstandings at Diagnosis
It is natural to feel anxious after receiving a diagnosis for a disease you can’t feel. Understanding these common misunderstandings can help you navigate the early stages of treatment:
- “If it doesn’t hurt, it isn’t serious.” This is the most dangerous misconception. In NK, the lack of pain is a symptom of nerve damage, not a sign of healing [1][7].
- “My vision is fine, so my eye must be okay.” Even in early stages, NK can cause blurred vision by making the corneal surface irregular [8]. However, serious damage can occur before you notice a major change in how you see [3].
- “The surface looks healed, so the disease is gone.” Even if the top layer of your cornea (the epithelium) heals, the underlying nerve damage often remains [9]. NK is a chronic condition that requires long-term monitoring because the surface can break down again.
- “I can monitor my eye at home.” While you can watch for vision changes and new redness, a patient cannot reliably assess their own corneal sensation, epithelial defects, infection, or corneal thinning at home. This requires a slit-lamp examination by a specialist.
The Stages of the Disease
Doctors often use the Mackie classification to describe how far the disease has progressed [10]:
- Stage 1: The surface of the eye becomes unstable, often appearing dry or cloudy, but there is no open wound [1].
- Stage 2: A persistent epithelial defect (PED) develops. This is essentially a “sore” or “hole” in the top layer of the cornea that refuses to heal on its own [1][11].
- Stage 3: The damage reaches the deeper layers of the cornea, forming an ulcer. If left untreated, this can lead to “melting” (thinning) of the cornea or even a perforation (a hole through the eye) [1][10].
Why Early Recognition Matters
Early diagnosis is the key to protecting your sight. Because your eye’s natural healing powers are impaired, your medical team must step in to provide that protection manually. This might include using preservative-free artificial tears, specialized eye drops that mimic the missing nerve proteins, or temporary procedures to help the eye stay closed and moist [6][10].
By working closely with a specialist and following an individualized monitoring schedule, you can manage the “silent” nature of NK and prevent the disease from progressing [12][3].
Common questions in this guide
What is neurotrophic keratitis, and why can it be painless?
How is neurotrophic keratitis staged?
How do doctors check for neurotrophic keratitis?
What treatments may protect the cornea in neurotrophic keratitis?
When should someone with neurotrophic keratitis see a cornea specialist?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Have you used an aesthesiometer to measure the exact degree of sensation loss in my cornea?
- 2.What is my current Mackie stage, and does it involve the stroma or just the epithelium?
- 3.Are any of the eye drops I am currently using 'preserved' or potentially toxic to my corneal surface?
- 4.Based on my current stage, how often should I be seen for monitoring to catch progression before it affects my vision?
- 5.Do you specialize in corneal diseases, or should I be referred to a cornea specialist for my ongoing management?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
Neurotrophic keratitis: current challenges and future prospects.
Versura P, Giannaccare G, Pellegrini M, et al.
Eye and brain 2018; (10()):37-45 doi:10.2147/EB.S117261.
PMID: 29988739 - 2
Expert consensus on the identification, diagnosis, and treatment of neurotrophic keratopathy.
Dana R, Farid M, Gupta PK, et al.
BMC ophthalmology 2021; (21(1)):327 doi:10.1186/s12886-021-02092-1.
PMID: 34493256 - 3
Neurotrophic keratitis: inflammatory pathogenesis and novel therapies.
Wajnsztajn D, Faraj LA, Sanchez-Tabernero S, Solomon A
Current opinion in allergy and clinical immunology 2023; (23(6)):520-528 doi:10.1097/ACI.0000000000000942.
PMID: 37694830 - 4
Neurotrophic factors and corneal nerve regeneration.
Sacchetti M, Lambiase A
Neural regeneration research 2017; (12(8)):1220-1224 doi:10.4103/1673-5374.213534.
PMID: 28966630 - 5
Neurotrophic keratitis: Frequency, etiologies, clinical management and outcomes.
Saad S, Abdelmassih Y, Saad R, et al.
The ocular surface 2020; (18(2)):231-236 doi:10.1016/j.jtos.2019.11.008.
PMID: 31759182 - 6
Neurotrophic Keratopathy: Current Concepts, Management, and Emerging Treatments.
Cheung AY, Holland EJ
Cornea 2026; (45(6)):673-685 doi:10.1097/ICO.0000000000004055.
PMID: 42085714 - 7
Corneal Neurotization in the Setting of Facial Paralysis: A Comprehensive Review of Surgical Techniques.
Ziai K, Thomas S, Weller C, Lighthall JG
The Journal of craniofacial surgery 2021; (32(6)):2210-2214 doi:10.1097/SCS.0000000000007590.
PMID: 33654040 - 8
The molecular basis of neurotrophic keratopathy: Diagnostic and therapeutic implications. A review.
Ruiz-Lozano RE, Hernandez-Camarena JC, Loya-Garcia D, et al.
The ocular surface 2021; (19()):224-240 doi:10.1016/j.jtos.2020.09.007.
PMID: 33022412 - 9
Chitosan-based thermosensitive hydrogel with long-term release of murine nerve growth factor for neurotrophic keratopathy.
Wu J, Huang Y, Yu H, et al.
Neural regeneration research 2024; (19(3)):680-686 doi:10.4103/1673-5374.380908.
PMID: 37721301 - 10
Neurotrophic keratopathy: current challenges and future prospects.
NaPier E, Camacho M, McDevitt TF, Sweeney AR
Annals of medicine 2022; (54(1)):666-673 doi:10.1080/07853890.2022.2045035.
PMID: 35243932 - 11
Efficacy of Plasma Rich in Growth Factors (PRGF) in Stage 1 Neurotrophic Keratitis.
Ghalibafan S, Osei K, Amescua G, Sabater A
Research square 2023; doi:10.21203/rs.3.rs-3040369/v1.
PMID: 37461454 - 12
Neurotrophic keratopathy: An updated understanding.
The ocular surface 2023; (30()):129-138 doi:10.1016/j.jtos.2023.09.001.
PMID: 37666470
This page is for informational purposes only and does not constitute medical advice about neurotrophic keratitis. A cornea specialist should assess corneal sensation and the eye surface because damage can progress without pain.
Get notified when new evidence is published on neurotrophic keratoconjunctivitis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.